David Einhorn - DME Capital Management
Holding/activity history for Nuvation Bio Inc (NUVB.WS)
← All NUVB.WS superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 0 | 0.00 | Sell 100.00% | <0.01 | SEC | ||
| 2025 Q4 | 100,000 | <0.01 | $0.33 | $33,000 | SEC | ||
| 2025 Q3 | 100,000 | <0.01 | $0.20 | $20,210 | SEC | ||
| 2025 Q2 | 100,000 | <0.01 | $0.27 | $26,990 | SEC | ||
| 2025 Q1 | 100,000 | <0.01 | $0.32 | $32,000 | SEC | ||
| 2024 Q4 | 100,000 | <0.01 | $0.23 | $23,000 | SEC | ||
| 2024 Q3 | 100,000 | <0.01 | $0.10 | $9,790 | SEC | ||
| 2024 Q2 | 100,000 | <0.01 | $0.16 | $16,000 | SEC | ||
| 2024 Q1 | 100,000 | <0.01 | $0.30 | $30,250 | SEC | ||
| 2023 Q4 | 100,000 | <0.01 | $0.06 | $6,000 | SEC | ||
| 2023 Q3 | 100,000 | <0.01 | $0.10 | $10,000 | SEC | ||
| 2023 Q2 | 100,000 | <0.01 | $0.17 | $16,539 | SEC | ||
| 2023 Q1 | 100,000 | <0.01 | $0.12 | $12,000 | SEC | ||
| 2022 Q4 | 100,000 | <0.01 | $0.14 | $14,450 | SEC | ||
| 2022 Q3 | 100,000 | <0.01 | $0.20 | $20,000 | SEC | ||
| 2022 Q2 | 100,000 | <0.01 | $0.28 | $28,000 | SEC | ||
| 2022 Q1 | 100,000 | <0.01 | $0.81 | $81,000 | SEC | ||
| 2021 Q4 | 100,000 | 0.01 | $1.89 | $189,000 | SEC | ||
| 2021 Q3 | 100,000 | 0.02 | $2.56 | $256,000 | SEC | ||
| 2021 Q2 | 100,000 | 0.02 | $2.60 | $260,000 | SEC | ||
| 2021 Q1 | 100,000 | 0.02 | Buy | 0.02 | $2.67 | $267,000 | SEC |